IP Verse

Administration Of Deuterated Cftr Potentiators - EP3352757

PATENT ANALYSIS

Patent Details

Grant Date
Aug 16, 2023
Company
VERTEX PHARMACEUTICALS (EUROPE) LIMITED
Oppositions

GENERICS (U.K.) LIMITED

More patents of Vertex Pharmaceuticals (Europe) Limited

EP3352757

Want to monitor this patent?

Feel free to send us a message here and we will get back to you